The genetics of essential hypertension.
- Published in:
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 1, p. 5, doi. 10.1046/j.1365-2125.2001.01254.x
- By:
- Publication type:
- Article
Works matching IS 03065251 AND DT 2001 AND VI 51 AND IP 1
Results: 15
1
2
Drug treatment of obesity: from past failures to future successes?
- Published in:
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 1, p. 13, doi. 10.1046/j.1365-2125.2001.01294.x
- By:
- Publication type:
- Article
3
Population pharmacokinetics of thioTEPA and its active metabolite TEPA in patients undergoing high-dose chemotherapy.
- Published in:
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 1, p. 61, doi. 10.1046/j.1365-2125.2001.01301.x
- By:
- Publication type:
- Article
4
Risk factors in the development of adverse reactions to N-acetylcysteine in patients with paracetamol poisoning.
- Published in:
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 1, p. 87, doi. 10.1046/j.1365-2125.2001.01305.x
- By:
- Publication type:
- Article
5
Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting.
- Published in:
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 1, p. 81, doi. 10.1046/j.1365-2125.2001.01306.x
- By:
- Publication type:
- Article
6
Trans-3′-hydroxycotinine: Disposition kinetics, effects and plasma levels during cigarette smoking.
- Published in:
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 1, p. 53, doi. 10.1046/j.1365-2125.2001.01309.x
- By:
- Publication type:
- Article
7
Effect of dexmedetomidine, an α<sub>2</sub>-adrenoceptor agonist, on human pupillary reflexes during general anaesthesia.
- Published in:
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 1, p. 27, doi. 10.1046/j.1365-2125.2001.01311.x
- By:
- Publication type:
- Article
8
Potent inhibition of CYP2D6 by haloperidol metabolites: stereoselective inhibition by reduced haloperidol.
- Published in:
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 1, p. 45, doi. 10.1046/j.1365-2125.2001.01313.x
- By:
- Publication type:
- Article
9
Co-prescribing of SSRIs and TCAs in Australia: how often does it occur and who is doing it?
- Published in:
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 1, p. 93, doi. 10.1046/j.1365-2125.2001.01319.x
- By:
- Publication type:
- Article
10
Pharmacodynamic models for the cardiovascular effects of moxonidine in patients with congestive heart failure.
- Published in:
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 1, p. 35, doi. 10.1046/j.1365-2125.2001.01320.x
- By:
- Publication type:
- Article
11
Terbinafine-associated inhibition of dextromethorphan metabolism in Chinese subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 1, p. 107, doi. 10.1046/j.1365-2125.2001.01322.x
- By:
- Publication type:
- Article
12
Effect of α<sub>1</sub>-acid glycoprotein on the intracellular accumulation of the HIV protease inhibitors saquinavir, ritonavir and indinavir in vitro.
- Published in:
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 1, p. 99, doi. 10.1046/j.1365-2125.2001.01324.x
- By:
- Publication type:
- Article
13
Systemic bioavailability of fluticasone propionate administered as nasal drops and aqueous nasal spray formulations.
- Published in:
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 1, p. 103, doi. 10.1046/j.1365-2125.2001.01325.x
- By:
- Publication type:
- Article
14
Population modelling of the effect of inogatran, at thrombin inhibitor, on ex vivo coagulation time (APTT) in healthy subjects and patients with coronary artery disease.
- Published in:
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 1, p. 71, doi. 10.1046/j.1365-2125.2001.01326.x
- By:
- Publication type:
- Article
15
Genes for common diseases.
- Published in:
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 1, p. 1, doi. 10.1046/j.1365-2125.2001.01343.x
- By:
- Publication type:
- Article